COGT
Price
$7.08
Change
-$0.14 (-1.94%)
Updated
Jun 13 closing price
Capitalization
806.1M
58 days until earnings call
TNFA
Price
$0.14
Change
-$0.01 (-6.67%)
Updated
Jun 13 closing price
Capitalization
1.94M
Interact to see
Advertisement

COGT vs TNFA

Header iconCOGT vs TNFA Comparison
Open Charts COGT vs TNFABanner chart's image
Cogent Biosciences
Price$7.08
Change-$0.14 (-1.94%)
Volume$1.51M
Capitalization806.1M
TNF Pharmaceuticals
Price$0.14
Change-$0.01 (-6.67%)
Volume$4.02M
Capitalization1.94M
COGT vs TNFA Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. TNFA commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a StrongBuy and TNFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (COGT: $7.08 vs. TNFA: $0.14)
Brand notoriety: COGT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 101% vs. TNFA: 81%
Market capitalization -- COGT: $806.1M vs. TNFA: $1.94M
COGT [@Biotechnology] is valued at $806.1M. TNFA’s [@Biotechnology] market capitalization is $1.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, both COGT and TNFA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while TNFA’s TA Score has 3 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • TNFA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, COGT is a better buy in the short-term than TNFA.

Price Growth

COGT (@Biotechnology) experienced а +4.12% price change this week, while TNFA (@Biotechnology) price change was -18.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

COGT is expected to report earnings on Aug 12, 2025.

TNFA is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($806M) has a higher market cap than TNFA($1.94M). COGT YTD gains are higher at: -9.231 vs. TNFA (-88.087). TNFA has higher annual earnings (EBITDA): -11.38M vs. COGT (-284.04M). COGT has more cash in the bank: 246M vs. TNFA (10.6M). TNFA has less debt than COGT: TNFA (18.3K) vs COGT (17.1M). COGT (0) and TNFA (0) have equivalent revenues.
COGTTNFACOGT / TNFA
Capitalization806M1.94M41,482%
EBITDA-284.04M-11.38M2,496%
Gain YTD-9.231-88.08710%
P/E RatioN/AN/A-
Revenue00-
Total Cash246M10.6M2,321%
Total Debt17.1M18.3K93,443%
FUNDAMENTALS RATINGS
COGT vs TNFA: Fundamental Ratings
COGT
TNFA
OUTLOOK RATING
1..100
3495
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
4397
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (9) in the null industry is significantly better than the same rating for COGT (82) in the Miscellaneous industry. This means that TNFA’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (69) in the Miscellaneous industry is in the same range as TNFA (100) in the null industry. This means that COGT’s stock grew similarly to TNFA’s over the last 12 months.

COGT's SMR Rating (96) in the Miscellaneous industry is in the same range as TNFA (97) in the null industry. This means that COGT’s stock grew similarly to TNFA’s over the last 12 months.

COGT's Price Growth Rating (43) in the Miscellaneous industry is somewhat better than the same rating for TNFA (97) in the null industry. This means that COGT’s stock grew somewhat faster than TNFA’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as TNFA (100) in the null industry. This means that COGT’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTTNFA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OGRIX33.45-0.33
-0.98%
Invesco Comstock Select R6
SSSYX448.65-5.04
-1.11%
State Street Equity 500 Index K
MBCSX23.99-0.30
-1.24%
MassMutual Blue Chip Growth R5
RGSCX23.70-0.30
-1.25%
Virtus KAR Global Small-Cap C
SSSFX22.88-0.37
-1.59%
SouthernSun Small Cap, N

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.94%
SPHDF - COGT
63%
Loosely correlated
N/A
XNCR - COGT
56%
Loosely correlated
-2.55%
IDYA - COGT
55%
Loosely correlated
-0.45%
ATXS - COGT
53%
Loosely correlated
+2.14%
CGON - COGT
53%
Loosely correlated
-2.42%
More